|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.12 USD | -1.75% |
|
+2.75% | +29.48% |
| May. 08 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
| May. 08 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
Karyopharm Therapeutics Inc. provided earnings guidance for the year 2022. For the year, the company expects total revenue to be in the range of $155 million to $165 million.
| 1st Jan change | Capi. | |
|---|---|---|
| +29.48% | 134M | |
| +8.63% | 115B | |
| +13.17% | 107B | |
| -12.76% | 22.31B | |
| -3.99% | 21.6B | |
| -7.19% | 18.23B | |
| -39.93% | 17.62B | |
| +6.67% | 14.26B | |
| +33.90% | 12.37B | |
| -28.60% | 8.28B |
KARYOPHARM THERAPEUTICS INC. 
